Buscar
Mostrando ítems 71-80 de 5025
Passive antiamyloid immunotherapy for Alzheimer's disease
(2020-05-01)
Purpose of reviewAntiamyloid therapy of Alzheimer's disease tackles the overproduction and clearance of the amyloid-beta peptide (Aβ). Immunotherapeutic compounds were tested in large-scale trials. We revisit the recent ...
Enfermedad de Alzheimer: Actualización en terapia farmacológica
(Sociedad Médica de Santiago, 2005)
Mitochondrial permeability transition pore as a suitable target for neuroprotective agents against alzheimer’s disease
(Bentham Science Publishers B.V., 2017)